Medicover Genetics Cyprus achieves ISO 27001 certification, strengthening information security in a rapidly digitalising healthcare landscape

Medicover Genetics Editorial Team|

Scientifically checkedView our editorial guidelines
Scientifically checked

Nicosia, Cyprus — Medicover Genetics Cyprus announces that it has successfully achieved ISO 27001 certification, the internationally recognised standard for information security management systems. This milestone reinforces the organisation’s commitment to maintaining the highest standards of security, governance, and operational integrity across all aspects of its business. As digital technologies continue to reshape healthcare and genetic services, organisations are managing increasing volumes of sensitive information across complex systems and platforms. In this environment, safeguarding information is not limited to data protection alone, but requires a comprehensive, structured approach to managing risk across systems, processes, and people.

ISO 27001 provides this framework, ensuring the confidentiality, integrity, and availability of information throughout the organisation. By achieving this certification, Medicover Genetics Cyprus demonstrates that it has implemented robust controls and a risk-based approach to information security, aligned with international best practices.

“This certification reflects our broader commitment to building a secure and resilient organisation,” said Dr. Marios Ioannides, Managing Director at Medicover Genetics Cyprus. “In today’s digital environment, information security is fundamental to maintaining trust. It requires continuous oversight, strong governance, and a culture of accountability across the organisation.”

The certification is the result of a coordinated, cross-functional effort, involving multiple teams and departments. It highlights the organisation’s ability to integrate security into its operations while supporting innovation and service delivery.

Beyond regulatory alignment, ISO 27001 certification strengthens trust with patients, partners, and stakeholders. It positions Medicover Genetics Cyprus as a reliable and secure provider in the field of genetic testing, capable of managing evolving cybersecurity risks while supporting ongoing digital transformation.

Medicover Genetics Cyprus remains committed to continuously improving its information security practices, ensuring that security, compliance, and operational excellence remain central to its growth strategy.

Last updated: October 7, 2026

Latest articles

All about genetics
Health and well-being
Hereditary diseases
  • VERACITY

    New-generation non-invasive prenatal screening from week 9 of pregnancy, analysing fetal cell-free DNA in maternal blood to detect selected chromosomal abnormalities with high sensitivity and specificity for early and reliable prenatal risk assessment.

  • Pharmacogenomics

    Enabling personalised treatments for safer, more effective care through genetic insights that guide optimal prescribing from the start and refine therapy when patients experience side effects or poor response.

  • ebiom+

    A comprehensive assessment of the endometrial microbiome and chronic endometritis pathogens to enhance clinical outcomes, prevent treatment delays, and support a more informed, personalised fertility care.

  • WES

    Advanced sequencing that simultaneously analyses a broad range of genes to detect the genetic basis of complex diseases, improve diagnostic accuracy, and inform recurrence risk assessment for better clinical decision-making.

Why Medicover Genetics

Leader in genetic testing with >25 years of experience in counselling and diagnostics

Comprehensive CE-IVD kit portfolio and seamless Technology Transfer solution for laboratories of any size

End-to-end clinical workflow from sample processing to sequencing analysis and reporting

CAP- and CLIA- and ISO15189 accredited, GMP- and ISO9001 and 13485 certified

Are you a patient?

Are you a physician?